SodaMelt Official Website › Side Effects
Side EffectsSodaMelt Side Effects, Interactions And Cautions
Loose stools, urgency and abdominal cramping are what a stimulant laxative produces when it works. Four of the eleven blend members are anthranoid stimulant laxatives, so those three are the mechanism rather than a surprise. Separate from them sit two documented medicine interactions, one from the calcium row and one from goldenseal, and neither is printed on the bottle.
The effects the mechanism predicts, the two interactions that are genuinely separate, and the label caution quoted in full.
What the SodaMelt bottle itself warns about
The bottle’s own words, reproduced before anything is added to them.
“Do not exceed recommended dose. Pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement. Keep out of reach of children. Do not use if safety seal is damaged or missing.”Caution, printed on the bottle
Four sentences, and they are the standard set. Do not exceed the dose. Three groups should consult a physician first. Keep it away from children. Do not use it if the safety seal is broken.
What the caution does not mention is anything specific to this blend. There is no line about stimulant laxatives, no line about how long to continue, and no line about goldenseal and prescription medicines. Those are the three this desk adds below, and they come from reading the ingredient list rather than from the packaging.
The SodaMelt effects that are the mechanism working
Five things buyers report, and the single mechanism all five come from.
| What you may notice | Why it happens | What it means |
|---|---|---|
| Looser stools | Reduced water reabsorption in the colon | The intended effect of a stimulant laxative |
| Urgency | Increased propulsive contractions | The same mechanism, felt as timing |
| Abdominal cramping | Those contractions, felt directly | Common, and the commonest reason people stop |
| Effect arriving 6 to 12 hours later | Colonic bacteria have to activate the glycosides first | Normal, and the reason a fixed hour helps |
| Yellow-brown urine discolouration | Anthraquinone pigments, harmless | Cosmetic, and it stops when the capsule does |
Five entries, all traceable to the same family of compounds at positions four, six, seven and nine of the blend.
Calling these side effects is slightly misleading, which is why the table separates what happens from what it means. A stimulant laxative that produced none of them would not be working (a review of anthranoid laxatives, a review of chronic stimulant laxative use).
Severity varies a great deal between people because the activation step is bacterial and gut flora vary. The same capsule can be barely noticeable in one person and distinctly uncomfortable in another, and there is no way to know in advance which of the two applies.
Cramping that is uncomfortable enough to need managing is a reason to stop the course rather than to reduce the dose, because the dose is already one capsule and there is nothing below it.
What long-running use of SodaMelt is and is not associated with
Four things the literature reports and four it does not establish.
Reported in the literature on anthranoid use
- Melanosis coli, a brown pigmentation of the colonic lining seen at colonoscopy, which reverses after the laxative stops (a prospective colonoscopy study, a study of melanosis coli at colonoscopy)
- A habit that can be hard to break, in the practical sense that a bowel accustomed to stimulation takes time to settle without it
- Fluid and electrolyte loss over a long run, which is the argument for the label's glass of water
- One case report of liver injury after cascara sagrada use (a case report of cascara sagrada liver injury)
Not supported, or not established either way
- The cathartic colon of older textbooks, which the modern reviews do not support well (a review of the cathartic colon question, a review of long-term stimulant laxative use)
- A demonstrated link to human colorectal cancer, which the prospective colonoscopy work did not find (a prospective colonoscopy study)
- Anything established about oat straw, gentian root or bentonite at these weights
- Anything this desk can say about the culture at position eleven, since no CFU count is declared
The National Toxicology Program fed whole-leaf aloe extract to rats and reported intestinal tumours at the doses used (the National Toxicology Program's rat study, the full NTP technical report). That finding is about aloe latex in rodents at study doses, not about a fraction of 250 mg in a person, and a broader review of aloe toxicity sets it in context (a review of aloe toxicity).
It is on this page because the leaf is on this label, because it is the reason aloe latex left the United States over-the-counter laxative monograph in 2002, and because leaving it out would be a choice made for the seller rather than for the reader.
Set all of that together and the honest summary is narrower than either side of the usual argument: a short course is well tolerated by most people, a long one is a habit worth questioning, and the catastrophic outcomes that circulate about this drug family are not well supported.
The two SodaMelt medicine interactions that are documented
Two rows on this panel with human evidence behind them, named by drug.
Calcium carbonate and levothyroxine: a timing problem with a known answer
Calcium carbonate binds levothyroxine in the gut and reduces how much of it is absorbed. The trial that established it gave 1,200 mg of calcium a day alongside the thyroid tablet for three months and measured the fall (the levothyroxine absorption study).
This capsule carries 100 mg, which is a twelfth of that, and the standard answer applies anyway because it costs nothing: four hours between the two (a systematic review of levothyroxine interactions, a review of what interferes with thyroxine absorption). It is a scheduling instruction rather than a warning.
Goldenseal and the liver enzymes: the one the bottle never mentions
Goldenseal inhibits CYP3A4 and CYP2D6 in humans, which changes how quickly the liver clears a long list of prescription drugs (a study of goldenseal and human cytochrome P450, the goldenseal-midazolam interaction study). Pharmacokinetic modelling puts numbers on the size of the effect (a pharmacokinetic modelling study), and the alkaloid work identifies which constituents are responsible (a 2020 study of goldenseal's individual alkaloids).
NCCIH reports metformin levels falling by about a quarter with goldenseal (NCCIH). A systematic review of herbal drug interactions puts it among the better-documented ones (a systematic review of herbal drug interactions).
The P-glycoprotein claim that circulates alongside this is weaker: a human digoxin study found no significant effect (a human digoxin study that found no effect). Naming the enzyme interaction and dropping the transporter one is the accurate version.
Goldenseal sits eighth of eleven by weight inside 250 mg, so the amount is small. The reason it still gets a section is that the consequence is not proportional to the dose in the way a benefit would be: a prescription with a narrow therapeutic window does not need much interference to matter.
Naming the capsule to whoever writes the prescription is the whole of the advice. It takes one sentence in an appointment and it replaces a page of general caution.
Bentonite is an adsorbent and adsorbents bind what is in the gut alongside them (a review of bentonite in drug delivery). It is at position ten of eleven so the quantity is small, and the practical habit is the same one the other two rows ask for: keep this capsule a couple of hours away from other oral medicines.
Who should not take SodaMelt at all
Seven groups, three of them the bottle’s own and four from the ingredient list.
- Anyone under the age of 18, which the bottle rules out in its own caution
- Pregnant or nursing mothers, until they have spoken to a physician, as the bottle asks
- Anyone with a known medical condition, on the same terms
- Anyone with a bowel obstruction, or suspected one, where a stimulant is the wrong tool
- Anyone with inflammatory bowel disease, unless their own clinician says otherwise
- Anyone taking levothyroxine who cannot reliably keep four hours between the two
- Anyone on a prescription cleared by CYP3A4 or CYP2D6 who has not raised it first
The first three are the label’s. The last four are this desk’s, and each comes from a specific row of the panel rather than from general caution.
There is a difference between a group the bottle excludes and a group that needs one conversation first, and the list above mixes the two deliberately. The audience page separates them into a table if that is the more useful shape.
When to stop taking SodaMelt
Four reasons to stop early and one reason to stop on schedule.
Stop and speak to a clinician if there is blood in the stool, if abdominal pain is severe rather than crampy, if vomiting starts, or if a bowel that worked before this capsule will not work comfortably without it.
Stop without needing anyone’s advice if the cramping is worse than the problem being solved. There is no lower dose to fall back to: one capsule is the serving the panel is calculated on, and halving it is not something a sealed capsule allows.
Stop at the end of a short course anyway. This is the part that separates this website from the seller’s page, and it is the reason the six-bottle tier is described on the pricing page as good value and a separate decision from taking six bottles back to back.
- The three common effects are the mechanism, not a fault
- Two prescription interactions are documented and both have simple answers
- A short course is well tolerated by most people
- A long course is a habit worth questioning rather than a danger to be alarmed about
SodaMelt safety questions
Does SodaMelt cause diarrhoea?
Looser stools are the intended effect of a stimulant laxative, and four of the eleven blend members are stimulant laxatives. Whether that reads as a result or as diarrhoea depends on how strongly it lands, which varies between people.
Does SodaMelt cause cramping?
Cramping is the propulsive contractions felt directly, so it comes from the same mechanism as the result. It is the commonest reason people stop a stimulant laxative.
Is SodaMelt safe to take every day?
This desk treats it as a short course. The literature on long-running anthranoid use is less alarming than the old textbooks suggest, and it still does not make a case for taking a stimulant indefinitely when the underlying reason has not changed.
Can SodaMelt be taken with prescription medicine?
Two rows need raising by name: the calcium, which wants four hours from levothyroxine, and the goldenseal, which inhibits CYP3A4 and CYP2D6. Bentonite is a third, smaller reason to keep a couple of hours from anything else swallowed.
Why is aloe vera in SodaMelt discussed as a toxicology question?
Because the label says leaf rather than gel, and the leaf brings the latex layer. The National Toxicology Program studied whole-leaf extract in rats and reported intestinal tumours at the doses it used, which is why aloe latex left the over-the-counter laxative monograph in 2002.
Will SodaMelt change the colour of anything?
Anthraquinone pigments can tint urine yellow-brown. It is cosmetic, it is well described for this drug family, and it stops when the capsule does.
Does SodaMelt interact with birth control?
Oral contraceptives are cleared partly by CYP3A4, which is one of the two enzymes goldenseal inhibits. The amount here is small and the interaction is documented, so it belongs in the same sentence to a prescriber as the rest.
Who publishes this SodaMelt website?
- van Gorkom BA, de Vries EG, Karrenbeld A, et al. Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther. 1999;13(4):443-52. PMID 10215727. https://pubmed.ncbi.nlm.nih.gov/10215727/
- Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol. 2003;36(5):386-9. PMID 12702977. https://pubmed.ncbi.nlm.nih.gov/12702977/
- Siegers CP, von Hertzberg-Lottin E, Otte M, et al. Anthranoid laxative abuse - a risk for colorectal cancer? Gut. 1993;34(8):1099-101. PMID 8174962. https://pubmed.ncbi.nlm.nih.gov/8174962/
- Katsumata R, Manabe N, Monobe Y, et al. Severe grade of melanosis coli is associated with a higher detection rate of colorectal adenoma. J Clin Biochem Nutr. 2022;71(2):165-171. PMID 36213792. https://pubmed.ncbi.nlm.nih.gov/36213792/
- Morales MA, Hernández D, Bustamante S, et al. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? J Toxicol. 2009;2009:287247. PMID 20107583. https://pubmed.ncbi.nlm.nih.gov/20107583/
- Noergaard M, Traerup Andersen J, Jimenez-Solem E, et al. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety? Scand J Gastroenterol. 2019;54(1):27-34. PMID 30700194. https://pubmed.ncbi.nlm.nih.gov/30700194/
- Nadir A, Reddy D, Van Thiel DH. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol. 2000;95(12):3634-7. PMID 11151906. https://pubmed.ncbi.nlm.nih.gov/11151906/
- Boudreau MD, Mellick PW, Olson GR, et al. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats. Toxicol Sci. 2013;131(1):26-39. PMID 22968693. https://pubmed.ncbi.nlm.nih.gov/22968693/
- Boudreau MD, Beland FA, Nichols JA, et al. Toxicology and carcinogenesis studies of a nondecolorized whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser. 2013;(577):1-266. PMID 24042237. https://pubmed.ncbi.nlm.nih.gov/24042237/
- Guo X, Mei N. Aloe vera: A review of toxicity and adverse clinical effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2016;34(2):77-96. PMID 26986231. https://pubmed.ncbi.nlm.nih.gov/26986231/
- National Center for Complementary and Integrative Health. Aloe Vera: Usefulness and Safety. Read 19 September 2026. States that in 2002 the FDA required manufacturers to remove aloe latex from over-the-counter laxative products for lack of safety data. https://www.nccih.nih.gov/health/aloe-vera
- Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822-5. PMID 10838651. https://pubmed.ncbi.nlm.nih.gov/10838651/
- Wiesner A, Gajewska D, Paśko P. Levothyroxine Interactions with Food and Dietary Supplements - A Systematic Review. Pharmaceuticals (Basel). 2021;14(3):206. PMID 33801406. https://pubmed.ncbi.nlm.nih.gov/33801406/
- Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-92. PMID 19942153. https://pubmed.ncbi.nlm.nih.gov/19942153/
- Chatterjee P, Franklin MR. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos. 2003;31(11):1391-7. PMID 14570772. https://pubmed.ncbi.nlm.nih.gov/14570772/
- Nguyen JT, Tian DD, Tanna RS, et al. An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations. J Pharmacol Exp Ther. 2023;387(3):252-264. PMID 37541764. https://pubmed.ncbi.nlm.nih.gov/37541764/
- Adiwidjaja J, Boddy AV, McLachlan AJ. Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. Eur J Clin Pharmacol. 2022;78(4):597-611. PMID 35048143. https://pubmed.ncbi.nlm.nih.gov/35048143/
- McDonald MG, Tian DD, Thummel KE, et al. Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects. Drug Metab Dispos. 2020;48(10):1018-1027. PMID 32591416. https://pubmed.ncbi.nlm.nih.gov/32591416/
- Gurley BJ, Swain A, Barone GW, et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos. 2007;35(2):240-5. PMID 17079360. https://pubmed.ncbi.nlm.nih.gov/17079360/
- National Center for Complementary and Integrative Health. Goldenseal: Usefulness and Safety. Read 19 September 2026. States that there is not enough evidence to determine whether goldenseal is useful for any health condition, that study doses were about 3 g a day, that it should not be used in pregnancy or breastfeeding, and that metformin levels fell about 25% in healthy adults given goldenseal extract with metformin. https://www.nccih.nih.gov/health/goldenseal
- Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med. 2012;78(13):1458-77. PMID 22855269. https://pubmed.ncbi.nlm.nih.gov/22855269/
- Park JH, Shin HJ, Kim MH, et al. Application of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systems. J Pharm Investig. 2016;46(4):363-375. PMID 32226640. https://pubmed.ncbi.nlm.nih.gov/32226640/
- Malinow MR, Bardana EJ Jr, Pirofsky B, et al. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science. 1982;216(4544):415-7. PMID 7071589. https://pubmed.ncbi.nlm.nih.gov/7071589/
- Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993;63(4):201-8. PMID 8513024. https://pubmed.ncbi.nlm.nih.gov/8513024/
Order SodaMelt with the safety reading done
Three expected effects, two documented interactions and a short course rather than a standing habit. 60 days from the purchase date if it does not suit.
One bottle $89 · six bottles $294 · 60-day money-back guarantee
Order SodaMelt On The Official WebsiteOne capsule a day · 30 per bottle · lot SOD-26/MY-2226